Overview

PCO-02 - Safety and Pharmacokinetics Trial

Status:
Unknown status
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Phase I clinical trial in healthy volunteers to study safety and pharmacokinetics of BPC-157, a pentadecapeptide from gastric source.
Phase:
Phase 1
Details
Lead Sponsor:
PharmaCotherapia d.o.o.
Collaborator:
Hospital Ángeles Tijuana
Treatments:
BPC 157